The Center for Disease Control and Prevention (CDC) are suggesting that susceptible US citizens over 18 years should consider the chikungunya vaccine if traveling to a country or territory experiencing an outbreak of the disease and are likely to have moderate exposure to mosquitoes or for stays longer than 6 months. The vaccine has been approved for use in the USA since November 2023. Read more
Advice for travellers
Chikungunya infections continue to spread across the Caribbean and Americas. The disease has symptoms similar to dengue fever and is transmitted by day-time feeding Aedes mosquitoes. There is no vaccine or prevention medication; using an effective, tropical-strength repellent to avoid insect bites is the best form of protection. Read more about Chikungunya.
Before you travel, call Travelvax Australia’s telephone advisory service on 1300 360 164 (toll-free from landlines) for country-specific advice and information. You can also make an appointment at your nearest Travelvax clinic to obtain vaccinations, medication to prevent or treat illness, and accessories for your journey.